Skip to main
LFST

LFST Stock Forecast & Price Target

LFST Analyst Ratings

Based on 8 analyst ratings
Buy
Strong Buy 38%
Buy 38%
Hold 25%
Sell 0%
Strong Sell 0%

Bulls say

LifeStance Health Gr is a mental healthcare company that operates as a provider of outpatient mental health services. The strong quarter results and impressive 11% growth rate in clinicians suggest that the LFST platform is efficient and effective. The rise in earnings demonstrates LFST is driving operational improvements. With a strong balance sheet, minimal reimbursement risk, and plenty of room to grow in a large and growing market, LFST is a top-quality organization with a bright future.

Bears say

LifeStance Health Gr is a well-positioned company in the highly demanded field of outpatient mental health services, serving primarily commercial patients with a large and diverse group of clinicians. However, there are concerns about the company's high fee-for-service model and potential saturation in the market, which could limit future growth. Additionally, the shift to a new EMR system and high investments in technology may impact profitability in the short term.

LFST has been analyzed by 8 analysts, with a consensus rating of Buy. 38% of analysts recommend a Strong Buy, 38% recommend Buy, 25% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of LifeStance Health Group and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About LifeStance Health Group (LFST) Forecast

Analysts have given LFST a Buy based on their latest research and market trends.

According to 8 analysts, LFST has a Buy consensus rating as of Aug 28, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $12.38, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $12.38, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

LifeStance Health Group (LFST)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.